Eleven Biotherapeutics Inc. (EBIO) Trading Up 8.2%
Shares of Eleven Biotherapeutics Inc. (NASDAQ:EBIO) were up 8.2% on Monday . The company traded as high as $2.98 and last traded at $2.91, with a volume of 1,709,658 shares. The stock had previously closed at $2.69.
The stock’s market cap is $47.41 million. The firm has a 50 day moving average price of $2.21 and a 200-day moving average price of $1.12.
In other news, major shareholder Boxer Capital, Llc sold 1,042,000 shares of the business’s stock in a transaction dated Monday, June 13th. The stock was sold at an average price of $2.74, for a total transaction of $2,855,080.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Eleven Biotherapeutics, Inc is a clinical-stage biopharmaceutical company. The Company through AMP-Rx, a protein engineering platform, is engaged in the discovery and development of protein therapeutics to treat diseases of the eye. The Company designs, engineers and generates a pipeline of protein therapeutic candidates that target cytokines, which are central to diseases of the eye.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.